When was OSSTEC founded?

OSSTEC was founded in 2021 and raised its 1st funding round 2 years after it was founded.

Where is OSSTEC located?

OSSTEC is headquartered in London, United Kingdom.

Who is the current CEO of OSSTEC?

Maxwell Munford of OSSTEC. They have also founded 1 company.

Which legal entities is OSSTEC associated with?

OSSTEC is associated with OSSTEC Ltd.

How many employees does OSSTEC have?

As of Sep 30, 2026, the latest employee count at OSSTEC is 21.

Is OSSTEC a funded company?

OSSTEC is a funded company, having raised a total of $4.68M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Apr 03, 2023.

How much is OSSTEC worth?

The latest valuation of OSSTEC is $***** as of Apr 03, 2023. This marks a decline of 1% from its peak valuation of $6.37M in Mar, 2023. This marks a decline of 1% from its peak valuation of $6.37M in Mar, 2023.

When was the latest funding round of OSSTEC?

OSSTEC's latest funding was a $***** Series A round on Apr 08, 2025, with participation from 5 investors. Its primary sector is Orthopedics. In United Kingdom, the Orthopedics sector has seen $48.1M in funding in 2026 to date.

Where does OSSTEC rank among its competitors?

OSSTEC ranks 5th amongst 259 active competitors, of which 50 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Nanochon, which secured $4.1M in Dec, 2025.

Who are the top competitors of OSSTEC?

OSSTEC's top competitors include CARLSMED, Orthofix and OssDsign. Among them, Nanochon secured the most recent funding round in December, 2025.

OSSTEC - 2026 Company Profile, Team, Funding, Competitors & Financials

OSSTEC is a series A company based in London (United Kingdom), founded in 2021 by Maxwell Munford. It operates as a Developer of regenerative orthopedic implants. OSSTEC has raised $4.68M in funding from investors like SFC Capital, Oxford Innovation Finance and Empirical Ventures, with a current valuation of $*****. The company has 259 active competitors, including 50 funded and 35 that have exited. Its top competitors include companies like CARLSMED, Orthofix and OssDsign.

Company Details

Developer of regenerative orthopedic implants. The company specializes in bone healing technology and offers partial knee implants that stimulate long-term bone growth.

Website: www.osstec.uk/
Social
Email ID: *****@osstec.uk

Key Metrics

Founded Year

2021

Location

London, United Kingdom

Stage

Series A

Total Funding

$4.68M in 2 rounds

Latest Funding Round

Series A, Apr 08, 2025, $*****

Post Money Valuation

$***** as on Apr 03, 2023

Investors

SFC Capital & 11 more

Ranked

5^th among 259 active competitors

Employee Count

21 as on Sep 30, 2026

Similar Companies

CARLSMED & 304 more

View OSSTEC's full profile

OSSTEC is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
OSSTEC Ltd CIN: 13500695 , United Kingdom, Active	Jul 07, 2021	-	9 (As on Jul 31, 2024)

OSSTEC has raised a total funding of $4.68M over 2 rounds. Its first funding round was on Apr 03, 2023. Its latest funding round was a Series A round on Apr 08, 2025 for $*****. 5 investors participated in its latest round. OSSTEC has 8 institutional investors and 4 angel investors.

Here is the list of recent funding rounds of OSSTEC:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 08, 2025	9810622	Series A	8552555	7523564	5213143	1987335
Apr 03, 2023	1825990	Seed	6813149	7283601	SFC Capital & 1 more	Science Angel Syndicate & 3 more

Access funding benchmarks and valuations. Sign up today!

View details of OSSTEC's funding rounds and investors

The founders of OSSTEC is Maxwell Munford. Maxwell Munford is the CEO of OSSTEC.

Here are the details of OSSTEC's key team members:

Maxwell Munford: Founder & CEO of OSSTEC.

View details of OSSTEC's Founder profiles and Board Members

OSSTEC's employee count trend

OSSTEC has 21 employees as of Sep 26. Here is OSSTEC's employee count trend over the years:

Uncover OSSTEC's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of OSSTEC include CARLSMED, Orthofix and OssDsign. Here is the list of Top 10 competitors of OSSTEC, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	CARLSMED 2018, San Diego (United States), Public	Developer of devices for spine surgery	$110M	B Capital, USVP & 7 others	63/100
2nd	Orthofix 1980, Lewisville (United States), Public	Developer of reconstructive and regenerative solutions for bone-related conditions	-	-	61/100
3rd	OssDsign 2011, Uppsala (Sweden), Public	Developer of regenerative 3D-printed orthopedic implants for craniofacial bone defects and trauma	$19.7M	SEB, Eiffel Investment Group & 11 others	60/100
4th	NuVasive 1997, San Diego (United States), Acquired	Developer of smart surgical devices for spinal surgery	$54.1M	Enterprise Partners Venture Capital, Domain Associates ... & 6 others	60/100
5th	OSSTEC 2021, London (United Kingdom), Series A	Developer of regenerative orthopedic implants	$4.68M	SFC Capital, Parkwalk & 10 others	56/100
6th	Arthrex 1981, Naples (United States), Funding Raised	Orthopedic medical device company with focus on arthroscopy	-	First Analysis	56/100
7th	Nanochon 2016, Burke (United States), Seed	Developer of 3D-printed implants for treating joint injuries	$11.3M	cultivate(MD), University of Virginia & 11 others	55/100
8th	K2M 2004, Leesburg (United States), Acquired	Spine solutions: implants, instruments, biologics, and enabling technologies	$21.5M	New Science Ventures, Bay City Capital & 3 others	54/100
9th	Hubly 2018, Chicago (United States), Seed	Developer of electrical bed system for intracranial access	$4.2M	Alchemist Accelerator, First Fund & 9 others	53/100
10th	Mizuho OSI 1978, Union City (United States), Acquired	Developer of surgical tables and consumables	-	-	53/100